Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma. - Karam JA; Msaouel P; Haymaker CL; Matin SF; Campbell MT; Zurita AJ; Shah AY; Wistuba II; Marmonti E; Duose DY; Parra ER; Soto LMS; et al. (Nature communications, 2023)